Fresenius Kabi intros generic Tepadina

Fresenius Kabi is offering Thiotepa for Injection.

The medication, which is a generic of Amneal/Adienne’s Tepadina, is available in 100 mg single-dose vials.

[Read more: Fresenius Kabi intros generic Foscavir]

“We are pleased to add Thiotepa for Injection to our portfolio of generic oncology medicines,” said John Ducker, president and CEO of Fresenius Kabi USA. “As a company whose purpose is ‘caring for life,’ we remain committed to supporting patients and their care teams by expanding access to affordable cancer treatment options.”

[Read more: Fresenius Kabi intros generic Alimta] 

Thiotepa for injection is an alkylating drug indicated for the treatment of adenocarcinoma of the breast or ovary; for controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities; and for treatment of superficial papillary carcinoma of the urinary bladder.